Vital KSK Holdings, Inc. (FRA:4GX)

Market Cap	367.96M -4.2%
Revenue (ttm)	3.28B +0.8%
Net Income	36.60M -7.0%
EPS	0.76 -4.7%
Shares Out	n/a
PE Ratio	10.05
Forward PE	n/a
Dividend	34.18 (458.85%)
Ex-Dividend Date	Mar 30, 2026

Volume	n/a
Average Volume	n/a
Open	7.45
Previous Close	7.45
Day's Range	7.45 - 7.45
52-Week Range	7.18 - 8.05
Beta	n/a
RSI	35.45
Earnings Date	May 12, 2026

About Vital KSK Holdings

Vital KSK Holdings, Inc. engages in the wholesale and retail sale of pharmaceutical products in Japan. The company sells poisonous or deleterious substances, narcotics, quasi-drugs, medical equipment and devices, sanitary materials, hygiene goods, nursing care products, and beverages; and test reagents, agricultural chemicals, epidemiological agents and materials, industrial chemicals, veterinary drugs, poisonous and deleterious substances, paints, pigments, dyes, regenerative medicine products, and other chemicals, as well as well as chemicals...

• Industry: Medical, Dental, and Hospital Equipment and Supplies
• Founded: 2009
• Employees: 3,756
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 4GX

Financial Performance

In fiscal year 2025, Vital KSK Holdings's revenue was 600.37 billion, an increase of 2.19% compared to the previous year's 587.48 billion. Earnings were 7.31 billion, an increase of 25.07%.

Financial numbers in JPY